Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Old Dominion Freight Line Inc (ODFL) vs Travere Therapeutics Inc. Common Stock (TVTX) Price & Performance

Old Dominion Freight Line IncTrade
Travere Therapeutics Inc. Common StockTrade

Price performance (Past 24H)

Key statistics

Old Dominion Freight Line Inc vs Travere Therapeutics Inc. Common Stock — how do they compare? Old Dominion Freight Line Inc trades at $184.79 (market cap $37.98B), while Travere Therapeutics Inc. Common Stock trades at $52.74 (market cap $4.88B). The key difference: Old Dominion Freight Line Inc is far larger — about 7.8× Travere Therapeutics Inc. Common Stock's market cap, and Old Dominion Freight Line Inc pays a 0.63% dividend while Travere Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Old Dominion Freight Line Inc for 77 Days and Travere Therapeutics Inc. Common Stock for 0 Days on average.

ODFLTVTX
Market Cap
$37.98B$4.88B
Volume
1,713,0561,668,577
Sector
IndustrialsHealth
52-Week High
$248.73$67.52
52-Week Low
$126.29$26.79
Typical Hold Time
77 Days0 Days
Enterprise Value
$37.72B$5.01B
Dividend Yield
0.63%—

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Old Dominion Freight Line Inc

Old Dominion Freight Line (ODFL) trades at $184.37, up 1.35% today, with a bearish technical signal and neutral oscillators. The company reported strong earnings beats in recent quarters, with Q2 2026 EPS of $1.68 exceeding the $1.54 estimate. Revenue for 2025 was $5.50B, with a net income margin of 19.44%. A 4.9% general rate increase effective October 5, 2026, aims to offset rising costs and support network investments.

ODFL presents a mixed outlook: robust profitability and analyst consensus target of $230.93 suggest upside, but high valuation multiples (P/E 35.23) and bearish technicals indicate near-term pressure. Key risks include freight demand volatility and competitive pressures, while institutional buying and earnings momentum support long-term growth potential.

Travere Therapeutics Inc. Common Stock

Travere Therapeutics (TVTX) trades at $51.80, down 0.42% on the day, with a neutral technical signal. The company reported strong revenue growth but persistent net losses, with a 2025 net income margin of -7.35%. Recent news includes new data presentations for its key drug FILSPARI and a CEO transition. Analyst consensus is strongly bullish with an 83.33% buy rating and a $70.60 price target, suggesting significant upside from the current price.

The outlook for TVTX hinges on the commercial success of FILSPARI, which shows promising sales growth, but profitability remains a challenge. Key risks include execution of the CEO transition, competitive pressures in nephrology treatments, and the company's ability to achieve sustained profitability. The high valuation multiples relative to negative earnings present a risk-reward balance for investors.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

ODFL

No sentiment data available yet.

TVTX
100% Buy0% Sell
Avg holding period · 0 Days

About Old Dominion Freight Line Inc

Old Dominion Freight Line is the fourth-largest less-than-truckload carrier in the United States, with more than 240 service centers and 9,200-plus tractors. OD is by far one of the most disciplined and efficient providers in the trucking industry, and its profitability and capital returns stand head and shoulders above its peers. Strategic initiatives revolve around increasing network density through market share gains and maintaining industry-leading service via consistent infrastructure investment.

Read more on ODFL →

About Travere Therapeutics Inc. Common Stock

Travere Therapeutics Inc. is a biopharmaceutical company focused on rare kidney and metabolic diseases. Its lead product, FILSPARI (sparsentan), is an oral medication for adults with IgA nephropathy, and it also markets Thiola for cystinuria.

Read more on TVTX →